Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00002932 · ClinicalTrials.gov registry record · Phase 2

Cisplatin and Radiation Therapy in Treating Patients With Stage IV Cancer of the Head and Neck

A Phase 2 study of Head and Neck Cancer, sponsored by Radiation Therapy Oncology Group.

Completed
Registry status
Phase 2
Development phase
60
Enrollment target
13
Study locations

NCT00002932 is a Phase 2 study of Head and Neck Cancer that has completed, run by Radiation Therapy Oncology Group. The registered enrollment target is 60 participants, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (77% lower). The trial reports 13 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00002932, a Phase 2 study of Head and Neck Cancer, has completed, sponsored by Radiation Therapy Oncology Group.

COMPLETED
Registry status
Phase 2
Development phase
60 participants
Enrollment target
13
Study locations

Study Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining radiation therapy with chemotherapy may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of cisplatin and radiation therapy in treating patients with stage IV cancer of the head and neck.

Conditions Studied

Head and Neck Cancer

Interventions

  • DRUG cisplatin
  • RADIATION radiation therapy

Study Locations (13)

Tennessee

  • CCOP - Baptist Cancer Institute - Memphis
  • University of Tennessee, Memphis Cancer Center - Memphis
  • Vanderbilt Cancer Center - Nashville

California

  • University of California San Diego Cancer Center - La Jolla
  • UCSF Cancer Center and Cancer Research Institute - San Francisco

Vermont

  • Fletcher-Allen Health Care - Burlington
  • Green Mountain Oncology Group - Rutland

Washington

  • University Cancer Center - Seattle
  • University of Washington Neutron Facility and Cancer Center - Seattle

Iowa

  • University of Iowa Hospitals and Clinics - Iowa City

Louisiana

  • MBCCOP - LSU Medical Center - New Orleans

Maryland

  • Marlene & Stewart Greenebaum Cancer Center, University of Maryland - Baltimore

Virginia

  • Naval Medical Center, Portsmouth - Portsmouth

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 1997-05
Est. Completion 2005-03
Phase Phase 2

Sponsor

Radiation Therapy Oncology Group

144 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00002932

The ClinicalTrials.gov registry entry for NCT00002932 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (77% lower). The listed sponsor is Radiation Therapy Oncology Group, which has 144 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Head and Neck Cancer appearing as the primary indexed condition, and to 2 interventions - of which cisplatin is the first listed.

NCT00002932 reports 13 study locations spanning 8 distinct geographic areas - top geographies include Tennessee, California, Vermont.

Frequently Asked Questions

What is clinical trial NCT00002932 about?

NCT00002932 is a clinical study titled "Cisplatin and Radiation Therapy in Treating Patients With Stage IV Cancer of the Head and Neck". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining radiation therapy with chemotherapy may kill more tumor cells. PURPOSE: Phase II trial to study the effe...

What is the current status of trial NCT00002932?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 1997-05. Estimated completion is 2005-03.

What conditions does trial NCT00002932 study?

This clinical trial studies the following conditions: Head and Neck Cancer.

What interventions are being tested in trial NCT00002932?

The interventions under investigation include: cisplatin (DRUG), radiation therapy (RADIATION).

Who is sponsoring clinical trial NCT00002932?

This trial is sponsored by Radiation Therapy Oncology Group, which has 144 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00002932 being conducted?

This trial has 13 study locations across California, Iowa, Louisiana, Maryland, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Head and Neck Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Head and Neck Cancer

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.